Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients

被引：0
|
作者：
Pardha Devaki
David Jencks
Brittany E. Yee
Mindie H. Nguyen
机构：
[1] Cleveland Clinic,Digestive Disease Institute
[2] Veterans’ Administration Health Care System,Department of Medicine
[3] University of California,School of Medicine
[4] Stanford University Medical Center,Division of Gastroenterology and Hepatology
来源：
Hepatology International | 2015年 / 9卷
关键词：
Hepatitis C; Genotype 5; Sustained virologic response; Peginterferon and ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 437
页数：6
相关论文
共 50 条
  • [1] Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
    Devaki, Pardha
    Jencks, David
    Yee, Brittany E.
    Nguyen, Mindie H.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (03) : 431 - 437
  • [2] Sustained Virological Response (SVR) to Standard Interferon (IFN) or Pegylated Interferon (PEG IFN) and Ribavirin (RBV) in Patients With Hepatitis C Virus Genotype 5 (HCV-5): Results of a Meta-Analysis of 423 Patients From 10 Individual Studies
    Devaki, Pardha
    Jencks, David S.
    Marupakula, Vidyasagargoud
    Nangia, Sharad
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2014, 146 (05) : S981 - S981
  • [3] Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis
    Aljumah, Abdulrahman A.
    Murad, Mohammad Hassan
    HEPATOLOGY RESEARCH, 2013, 43 (12) : 1255 - 1263
  • [4] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [5] Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
    Nguyen, Nghia H.
    McCormack, Shelley A.
    Vutien, Philip
    Yee, Brittany E.
    Devaki, Pardha
    Jencks, David
    Nguyen, Mindie H.
    INTERVIROLOGY, 2015, 58 (01) : 27 - 34
  • [6] Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis
    Thong, Vo Duy
    Poovorawan, Kittiyod
    Tangkijvanich, Pisit
    Wasitthankasem, Rujipat
    Vongpunsawad, Sompong
    Poovorawan, Yong
    INTERVIROLOGY, 2015, 58 (06) : 373 - 381
  • [7] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
  • [8] Pegylated Interferon and Ribavirin Therapy for 24 Weeks Versus Shorter Duration for Patients with Hepatitis C Virus Genotype 2 and 3 Infection and Rapid Virologic Response: A Meta-Analysis
    Arif, Murtaza
    Thapar, Manish
    Matteson, Michelle L.
    Choudhary, Abhishek
    Szary, Nicholas M.
    Puli, Srinivas R.
    Bechtold, Matthew L.
    GASTROENTEROLOGY, 2009, 136 (05) : A791 - A791
  • [9] IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis
    Zheng, Hao
    Li, Man
    Chi, Bing
    Wu, Xiao-xue
    Wang, Jia
    Liu, Dian-Wu
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (05) : 576 - 583
  • [10] Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
    Fardin Dolatimehr
    Hamidreza Karimi-Sari
    Mohammad Saeid Rezaee-Zavareh
    Seyed Moayed Alavian
    Bita Behnava
    Mohammad Gholami-Fesharaki
    Heidar Sharafi
    DARU Journal of Pharmaceutical Sciences, 25
12345